Replies to post #17051 on Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

Mastiffs for life....what do you mean by, "Where would we be right now with cash in hand without it."?

Without the cash we would be at greater risk. You never know when you can raise funds again at as high as $13.

To be focused obsessively on current share price makes no investing sense. Focus on trial development status and cash. Everything else is noise.

[fbg0316]

The most recent reported cash and short term assets (which is cash put into short term bonds) was $142 million so without the post Amgen dilution we would be at $112 million and likely around a $16 pps.